Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of ciprofloxacin combined with azlocillin.

Literature DB >> 2935078

In vitro activity of ciprofloxacin combined with azlocillin.

Abstract

A ciprofloxacin plus azlocillin broth microdilution checkerboard was evaluated against 125 aerobic gram-negative and gram-positive bacteria. Synergism (sigma FIC less than or equal to 0.5) occurred among 56% of Pseudomonas aeruginosa, 30% of Acinetobacter species, and 40% of Staphylococcus aureus studied. Antagonism (sigma FIC greater than or equal to 2) was present in less than 1% of the organisms.

Entities: Chemical Species

Mesh：

Substances：

Year: 1985 PMID： 2935078 PMCID： PMC180346 DOI： 10.1128/AAC.28.6.849

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

11 in total

1. A simple method for storage of bacteria at--76 degrees C.

Authors: R K Feltham; A K Power; P A Pell; P A Sneath
Journal: J Appl Bacteriol Date: 1978-04

2. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

Authors: H O Hallander; K Dornbusch; L Gezelius; K Jacobson; I Karlsson
Journal: Antimicrob Agents Chemother Date: 1982-11 Impact factor: 5.191

3. Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage.

Authors: P R McMaster; E A Robertson; F G Witebsky; J D MacLowry
Journal: Antimicrob Agents Chemother Date: 1978-05 Impact factor: 5.191

4. Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin.

Authors: M E Gombert; T M Aulicino
Journal: Antimicrob Agents Chemother Date: 1984-12 Impact factor: 5.191

In vitro activity of ciprofloxacin combined with azlocillin.

1. A simple method for storage of bacteria at--76 degrees C.

2. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

3. Evaluation of a dispensing instrument (Dynatech MIC-2000) for preparing microtiter antibiotic plates and testing their potency during storage.

4. Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin.

5. In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.

6. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

7. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

8. In vitro activity of ciprofloxacin (Bay o 9867).

9. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

10. In vitro activity of ciprofloxacin against aerobic gram-negative bacteria.

Review 1. Screening and treatment of infections caused by resistant enterococci.

Review 2. Synergy and antagonism of combinations with quinolones.

Review 3. Current perspectives on glycopeptide resistance.

4. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.

5. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.

Review 6. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Review 7. Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

8. Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.

9. In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.

Review 10. Fluoroquinolone antimicrobial agents.